Efficacy of Irisin on neurological and tissue-related outcomes in ischemic brain injuries; a scoping review

Background: Evidence indicates the protective role of Irisin on nervous tissue following ischemic events, by preventing the cascades of secondary damage. We conducted this scoping review to summarize what has been discovered so far on the neuroprotective effects of Irisin, with a focus on ischemic...

Full description

Bibliographic Details
Main Authors: Seyedeh Romina Rafiei Alavi, Seyedeh Niloufar Rafiei Alavi, Amirmohammad Toloui, Arash Sarveazad, Mahmoud Yousefifard
Format: Article
Language:English
Published: Shahid Beheshti University of Medical Sciences 2023-08-01
Series:طب اورژانس ایران
Subjects:
Online Access:https://journals.sbmu.ac.ir/iranjem/article/view/42858
_version_ 1797692782082523136
author Seyedeh Romina Rafiei Alavi
Seyedeh Niloufar Rafiei Alavi
Amirmohammad Toloui
Arash Sarveazad
Mahmoud Yousefifard
author_facet Seyedeh Romina Rafiei Alavi
Seyedeh Niloufar Rafiei Alavi
Amirmohammad Toloui
Arash Sarveazad
Mahmoud Yousefifard
author_sort Seyedeh Romina Rafiei Alavi
collection DOAJ
description Background: Evidence indicates the protective role of Irisin on nervous tissue following ischemic events, by preventing the cascades of secondary damage. We conducted this scoping review to summarize what has been discovered so far on the neuroprotective effects of Irisin, with a focus on ischemic stroke. Methods: Search strategies were designed based on the keywords related to ischemic stroke and Irisin. Next, an extensive search in Medline, Embase, Scopus, and Web of Science was conducted by the end of April 2022. Two researchers independently reviewed the articles and performed the screening of the selected papers according to the inclusion criteria. Finally, the required data were extracted to a checklist designed based on the PRISMA guideline. The “meta” package was used for the meta-analysis, and heterogeneity between studies was assessed using the I2 test. Results: Pooled data analysis showed that the Irisin administration significantly improved the neurological function following cerebral ischemia / reperfusion injuries (SMD = 3.08; 95% CI: 1.10, 5.06; p<0.0001). Additionally, meta-regression demonstrated that the improvement in neurological function was directly related to the dose of administered Irisin (meta-regression coefficient = 0.03; p = 0.02). Moreover, Irisin administration significantly reduced the volume of infarcted lesions (SMD= -3.14; 95% CI: -4.23, -2.04; p<0.0001), the amount of edema in the brain (SMD= -2.30; 95% CI: -4.07, -0.53; p<0.0001), and the extend of neuronal-cell apoptosis rate (SMD= -4.67; 95% CI: -8.15, -1.19; p<0.0001). Conclusion: The present study demonstrates that the administration of Irisin in animal models of cerebral ischemia / reperfusion injuries is associated with a significant dose-dependent improvement in neurological function. Due to the limited number of articles, more research on the aim of finding the optimum Irisin dosage is in high demand.
first_indexed 2024-03-12T02:33:32Z
format Article
id doaj.art-22ce505b4d2b4f77a006246711ee3eb9
institution Directory Open Access Journal
issn 2383-3645
language English
last_indexed 2024-03-12T02:33:32Z
publishDate 2023-08-01
publisher Shahid Beheshti University of Medical Sciences
record_format Article
series طب اورژانس ایران
spelling doaj.art-22ce505b4d2b4f77a006246711ee3eb92023-09-05T03:34:27ZengShahid Beheshti University of Medical Sciencesطب اورژانس ایران2383-36452023-08-0110110.22037/ijem.v10i1.42858Efficacy of Irisin on neurological and tissue-related outcomes in ischemic brain injuries; a scoping reviewSeyedeh Romina Rafiei AlaviSeyedeh Niloufar Rafiei AlaviAmirmohammad TolouiArash SarveazadMahmoud Yousefifard0Iran University of Medical Sciences Background: Evidence indicates the protective role of Irisin on nervous tissue following ischemic events, by preventing the cascades of secondary damage. We conducted this scoping review to summarize what has been discovered so far on the neuroprotective effects of Irisin, with a focus on ischemic stroke. Methods: Search strategies were designed based on the keywords related to ischemic stroke and Irisin. Next, an extensive search in Medline, Embase, Scopus, and Web of Science was conducted by the end of April 2022. Two researchers independently reviewed the articles and performed the screening of the selected papers according to the inclusion criteria. Finally, the required data were extracted to a checklist designed based on the PRISMA guideline. The “meta” package was used for the meta-analysis, and heterogeneity between studies was assessed using the I2 test. Results: Pooled data analysis showed that the Irisin administration significantly improved the neurological function following cerebral ischemia / reperfusion injuries (SMD = 3.08; 95% CI: 1.10, 5.06; p<0.0001). Additionally, meta-regression demonstrated that the improvement in neurological function was directly related to the dose of administered Irisin (meta-regression coefficient = 0.03; p = 0.02). Moreover, Irisin administration significantly reduced the volume of infarcted lesions (SMD= -3.14; 95% CI: -4.23, -2.04; p<0.0001), the amount of edema in the brain (SMD= -2.30; 95% CI: -4.07, -0.53; p<0.0001), and the extend of neuronal-cell apoptosis rate (SMD= -4.67; 95% CI: -8.15, -1.19; p<0.0001). Conclusion: The present study demonstrates that the administration of Irisin in animal models of cerebral ischemia / reperfusion injuries is associated with a significant dose-dependent improvement in neurological function. Due to the limited number of articles, more research on the aim of finding the optimum Irisin dosage is in high demand. https://journals.sbmu.ac.ir/iranjem/article/view/42858FNDC5 proteinNeurological functionStrokeInfarct areaMotor function
spellingShingle Seyedeh Romina Rafiei Alavi
Seyedeh Niloufar Rafiei Alavi
Amirmohammad Toloui
Arash Sarveazad
Mahmoud Yousefifard
Efficacy of Irisin on neurological and tissue-related outcomes in ischemic brain injuries; a scoping review
طب اورژانس ایران
FNDC5 protein
Neurological function
Stroke
Infarct area
Motor function
title Efficacy of Irisin on neurological and tissue-related outcomes in ischemic brain injuries; a scoping review
title_full Efficacy of Irisin on neurological and tissue-related outcomes in ischemic brain injuries; a scoping review
title_fullStr Efficacy of Irisin on neurological and tissue-related outcomes in ischemic brain injuries; a scoping review
title_full_unstemmed Efficacy of Irisin on neurological and tissue-related outcomes in ischemic brain injuries; a scoping review
title_short Efficacy of Irisin on neurological and tissue-related outcomes in ischemic brain injuries; a scoping review
title_sort efficacy of irisin on neurological and tissue related outcomes in ischemic brain injuries a scoping review
topic FNDC5 protein
Neurological function
Stroke
Infarct area
Motor function
url https://journals.sbmu.ac.ir/iranjem/article/view/42858
work_keys_str_mv AT seyedehrominarafieialavi efficacyofirisinonneurologicalandtissuerelatedoutcomesinischemicbraininjuriesascopingreview
AT seyedehniloufarrafieialavi efficacyofirisinonneurologicalandtissuerelatedoutcomesinischemicbraininjuriesascopingreview
AT amirmohammadtoloui efficacyofirisinonneurologicalandtissuerelatedoutcomesinischemicbraininjuriesascopingreview
AT arashsarveazad efficacyofirisinonneurologicalandtissuerelatedoutcomesinischemicbraininjuriesascopingreview
AT mahmoudyousefifard efficacyofirisinonneurologicalandtissuerelatedoutcomesinischemicbraininjuriesascopingreview